Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 383

1.

Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a single-center observational study.

Yokoyama Y, Ito T, Yasuda T, Furubeppu H, Kamikokuryo C, Yamada S, Maruyama I, Kakihana Y.

Thromb J. 2019 Jan 14;17:1. doi: 10.1186/s12959-018-0190-4. eCollection 2019.

2.

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study.

Lensing AWA, Male C, Young G, Kubitza D, Kenet G, Patricia Massicotte M, Chan A, Molinari AC, Nowak-Goettl U, Pap ÁF, Adalbo I, Smith WT, Mason A, Thelen K, Berkowitz SD, Crowther M, Schmidt S, Price V, Prins MH, Monagle P.

Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018.

3.

Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series.

Greenfield G, McMullin MF.

Thromb J. 2018 Dec 19;16:33. doi: 10.1186/s12959-018-0187-z. eCollection 2018.

4.

Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era.

Louw S, Gounden R, Mayne ES.

Thromb J. 2018 Dec 13;16:35. doi: 10.1186/s12959-018-0189-x. eCollection 2018.

5.

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study.

Willmann S, Thelen K, Kubitza D, Lensing AWA, Frede M, Coboeken K, Stampfuss J, Burghaus R, Mück W, Lippert J.

Thromb J. 2018 Dec 4;16:32. doi: 10.1186/s12959-018-0185-1. eCollection 2018.

6.

Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study.

Kubitza D, Willmann S, Becka M, Thelen K, Young G, Brandão LR, Monagle P, Male C, Chan A, Kennet G, Martinelli I, Saracco P, Lensing AWA.

Thromb J. 2018 Dec 4;16:31. doi: 10.1186/s12959-018-0186-0. eCollection 2018.

7.

Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report.

Mayne ES, Tait M, Jacobson BF, Pillay E, Louw SJ.

Thromb J. 2018 Nov 26;16:30. doi: 10.1186/s12959-018-0184-2. eCollection 2018.

8.

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study.

Sennesael AL, Larock AS, Douxfils J, Elens L, Stillemans G, Wiesen M, Taubert M, Dogné JM, Spinewine A, Mullier F.

Thromb J. 2018 Nov 12;16:28. doi: 10.1186/s12959-018-0183-3. eCollection 2018.

9.

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis.

Chan A, Lensing AWA, Kubitza D, Brown G, Elorza D, Ybarra M, Halton J, Grunt S, Kenet G, Bonnet D, Santamaria A, Saracco P, Biss T, Climent F, Connor P, Palumbo J, Thelen K, Smith WT, Mason A, Adalbo I, Berkowitz SD, Hurst E, van Kesteren J, Young G, Monagle P.

Thromb J. 2018 Nov 1;16:29. doi: 10.1186/s12959-018-0182-4. eCollection 2018.

10.

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events.

Dragoni F, Chiarotti F, Iori AP, La Rocca U, Cafolla A.

Thromb J. 2018 Oct 22;16:26. doi: 10.1186/s12959-018-0181-5. eCollection 2018.

11.
12.

Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.

Noubiap JJ, Temgoua MN, Tankeu R, Tochie JN, Wonkam A, Bigna JJ.

Thromb J. 2018 Oct 4;16:27. doi: 10.1186/s12959-018-0179-z. eCollection 2018.

13.

Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin.

Arishima T, Ito T, Yasuda T, Yashima N, Furubeppu H, Kamikokuryo C, Futatsuki T, Madokoro Y, Miyamoto S, Eguchi T, Haraura H, Maruyama I, Kakihana Y.

Thromb J. 2018 Sep 28;16:24. doi: 10.1186/s12959-018-0178-0. eCollection 2018.

14.

Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study.

Gebreyohannes EA, Bhagavathula AS, Tegegn HG.

Thromb J. 2018 Sep 18;16:22. doi: 10.1186/s12959-018-0177-1. eCollection 2018.

15.

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study.

Cohen AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, Mantovani LG, Bach M; COSIMO Investigators.

Thromb J. 2018 Sep 4;16:21. doi: 10.1186/s12959-018-0176-2. eCollection 2018.

16.

Arteriolar vs. valvular thrombosis: Pick your evil!

Berry A, Degheim G, Saba S.

Thromb J. 2018 Aug 29;16:23. doi: 10.1186/s12959-018-0175-3. eCollection 2018.

17.
18.

TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.

Chang JC.

Thromb J. 2018 Aug 11;16:20. doi: 10.1186/s12959-018-0174-4. eCollection 2018. Review.

19.

Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study.

Matsumoto H, Takeba J, Umakoshi K, Kikuchi S, Ohshita M, Annen S, Moriyama N, Nakabayashi Y, Sato N, Aibiki M.

Thromb J. 2018 Aug 1;16:17. doi: 10.1186/s12959-018-0171-7. eCollection 2018.

20.

Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens.

Seyoum M, Enawgaw B, Melku M.

Thromb J. 2018 Jul 17;16:16. doi: 10.1186/s12959-018-0170-8. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center